Company profile: Dotmatics
1.1 - Company Overview
Company description
- Provider of an enterprise R&D scientific software platform connecting science, data, and decision-making, with applications including electronic laboratory notebook (Dotmatics ELN), Luma AI-native multimodal scientific intelligence, scientific search, small molecule drug discovery solution, and visualization & analytics to streamline research workflows and accelerate innovation.
Products and services
- Luma: An AI-native multimodal scientific intelligence platform that integrates scientific tools and data sources to streamline research workflows and enhance decision-making through AI-driven analytics
- Dotmatics ELN: A cross-disciplinary electronic laboratory notebook that captures, stores, and shares experimental data across scientific disciplines, supporting data-driven decision-making
- Small Molecule Drug Discovery Solution: A small-molecule-focused platform that manages experiments, molecules, samples, and assay data for drug discovery, facilitating informed decision-making with advanced visualization tools
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Dotmatics
Intomics
HQ: Denmark
Website
- Description: Provider of core biological insights from analysis and integration of biomedical big data, leveraging bioinformatics and systems biology to accelerate and improve drug discovery and development through optimized usage of biomedical data.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Intomics company profile →
Jungla
HQ: United States
Website
- Description: Provider of biotechnology solutions for clinical genetic and genomic testing, combining functional genomics, computational biophysics, and computer science. Offers the Molecular Evidence Platform, an active learning engine that integrates clinical knowledge to generate, evaluate, audit, and distribute evidence models, and solutions that augment and optimize clinical genetic and genomic test guidance.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Jungla company profile →
Global Q
HQ: United States
Website
- Description: Provider of cloud-based quality management software and guided compliance with data and complaints management for manufacturers. Solutions include MediGPT for medical device and pharmaceutical firms to improve productivity, cost savings, speed to market and quality; Optiqs360 Digital applying intelligence across operations; IntelliWriter for one-click document automation; and customer success services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Global Q company profile →
PlanDomino
HQ: Ireland
Website
- Description: Provider of a fully digitised system simplifying management of complex testing laboratories by managing samples, people, instruments, and non-test lab activities, which can offer savings north of 50% at reduced cost and with shorter lead-in time.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PlanDomino company profile →
ESAC
HQ: United States
Website
- Description: Provider of research data management, bioinformatics, and healthcare information technology solutions for government, commercial, and academic clients, addressing health IT interoperability and standards, genomics and proteomics technologies, data coordination, and big data integration and visualization.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ESAC company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Dotmatics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Dotmatics
2.2 - Growth funds investing in similar companies to Dotmatics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Dotmatics
4.2 - Public trading comparable groups for Dotmatics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →